M Angelica Selim Selected Research

M Angelica Selim Research Topics

Disease

15	Melanoma (Melanoma, Malignant) 08/2022 - 08/2003
13	Neoplasms (Cancer) 08/2022 - 02/2005
3	Wounds and Injuries (Trauma) 03/2016 - 11/2011
3	Contracture 11/2014 - 06/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2012 - 03/2006
3	Erythema 10/2005 - 07/2002
2	Sarcoma (Soft Tissue Sarcoma) 06/2020 - 01/2018
2	Basal Cell Carcinoma (Rodent Ulcer) 04/2017 - 03/2006
2	Hypertrophic Cicatrix (Hypertrophic Scar) 03/2016 - 11/2014
2	Cicatrix (Scar) 03/2016 - 11/2011
2	Disease Progression 05/2013 - 01/2011
2	Fibrosis (Cirrhosis) 11/2011 - 01/2011
2	Nevus (Nevi) 02/2011 - 02/2005
2	Margins of Excision 03/2010 - 08/2003
2	Sunburn 10/2005 - 06/2003
1	Drug Hypersensitivity Syndrome 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Amyloidosis 09/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Burns 03/2016
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 01/2016
1	Brain Diseases (Brain Disorder) 04/2015
1	Toxoplasmosis 04/2015
1	Lymphadenopathy 11/2012
1	Weight Loss (Weight Reduction) 05/2012
1	Inflammation (Inflammations) 05/2012
1	Pseudolymphoma 05/2012
1	Edema (Dropsy) 11/2011
1	Dermatitis Herpetiformis (Disease, Duhring's) 11/2011
1	Erythema elevatum diutinum 11/2011
1	Lymphatic Metastasis 06/2011
1	Dupuytren Contracture (Dupuytrens Contracture) 06/2011
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 02/2011
1	Keloid 01/2011
1	Lymphangioma (Cavernous Lymphangioma) 09/2010
1	Crohn Disease (Crohn's Disease) 09/2010

Drug/Important Bio-Agent (IBA)

3	Melanins (Melanin)IBA 08/2022 - 02/2011
3	CollagenIBA 03/2016 - 07/2002
3	Temozolomide (Temodar)FDA LinkGeneric 07/2010 - 05/2007
3	Melphalan (Alkeran)FDA LinkGeneric 07/2010 - 05/2007
2	Coloring Agents (Dyes)IBA 04/2017 - 04/2015
2	Sorafenib (BAY 43-9006)FDA Link 12/2010 - 07/2010
2	Cadherins (E-Cadherin)IBA 05/2008 - 07/2006
2	AntioxidantsIBA 10/2005 - 06/2003
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2005 - 06/2003
2	alpha-Tocopherol FDA Link 10/2005 - 06/2003
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2023
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	IpilimumabIBA 01/2021
1	Sucrose (Saccharose)IBA 06/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 09/2018
1	Panitumumab (Vectibix)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	ganitumabIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Deubiquitinating EnzymesIBA 07/2016
1	Polyurethanes (Polyurethane)IBA 03/2016
1	Adalimumab (Humira)FDA Link 01/2016
1	Dutasteride (Avodart)FDA Link 05/2013
1	Lactose FDA LinkGeneric 11/2012
1	Oxidoreductases (Dehydrogenase)IBA 11/2012
1	Carcinoembryonic AntigenIBA 08/2012
1	Keratin-7 (Cytokeratin 7)IBA 08/2012
1	Keratin-15 (Keratin 15)IBA 08/2012
1	NestinIBA 08/2012
1	CAM 5.2 antigenIBA 08/2012
1	Keratin-19 (Keratin 19)IBA 08/2012
1	Interferon-alpha (Interferon Alfa)IBA 05/2012
1	PlasticsIBA 05/2012
1	Complement System Proteins (Complement)IBA 01/2012
1	Immunoglobulin A (IgA)IBA 11/2011
1	FibrinIBA 11/2011
1	rho-Associated KinasesIBA 11/2011
1	TransglutaminasesIBA 11/2011
1	fasudil (AT 877)IBA 11/2011
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 06/2011
1	Fluphenazine (Prolixin)FDA LinkGeneric 06/2011
1	CalciumIBA 06/2011
1	anthraceneIBA 06/2011
1	Acetates (Acetic Acid Esters)FDA Link 06/2011
1	pheomelaninIBA 02/2011
1	eumelaninIBA 02/2011
1	Angiotensin IIIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	Hormones (Hormone)IBA 01/2011
1	PD 123319IBA 01/2011
1	Myosin Type IIIBA 01/2011
1	Proto-Oncogene Proteins B-rafIBA 07/2010

Therapy/Procedure

9	Therapeutics 01/2021 - 07/2002
2	Radiotherapy 09/2010 - 03/2010
2	Drug Therapy (Chemotherapy) 07/2010 - 05/2008
1	Immunotherapy 01/2018
1	Skin Transplantation (Skin Grafting) 03/2016
1	Contraindications 07/2015
1	Stem Cell Transplantation 04/2015
1	Aftercare (After-Treatment) 08/2012
1	Body Contouring 05/2012
1	Abdominoplasty 05/2012